Long-term complete remission by infusion of ex vivo-expanded donor-derived CD4(+) lymphocytes for treating an early relapse of Hodgkin lymphoma after cord blood transplantation

Leuk Lymphoma. 2016;57(1):230-2. doi: 10.3109/10428194.2015.1041390. Epub 2015 Jun 18.

Authors

Tomoya Muto¹, Chikako Ohwada¹, Atsuko Yamazaki¹, Yasumasa Sugita¹, Shokichi Tsukamoto¹, Shio Sakai^{1

2}, Yusuke Takeda¹, Naoya Mimura^{1

2}, Masahiro Takeuchi¹, Emiko Sakaida¹, Tohru Iseki^{1

2}, Norio Shimizu³, Tomohiro Morio⁴, Chiaki Nakaseko¹

Affiliations

¹ a Department of Hematology , Chiba University Hospital , Chiba , Japan.
² b Division of Transfusion Medicine and Cell Therapy, Chiba University Hospital , Chiba , Japan.
³ c Department of Virology , Medical Research Institute, Tokyo Medical and Dental University , Tokyo , Japan.
⁴ d Department of Pediatrics and Developmental Biology , Tokyo Medical and Dental University , Tokyo , Japan.

PMID: 25962436
DOI: 10.3109/10428194.2015.1041390

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
CD4-Positive T-Lymphocytes / immunology*
Cord Blood Stem Cell Transplantation
Female
Hodgkin Disease / diagnosis
Hodgkin Disease / immunology*
Hodgkin Disease / therapy*
Humans
Immunotherapy, Adoptive*
Positron-Emission Tomography
Recurrence
Tomography, X-Ray Computed
Treatment Outcome